Skip to main content
  • India achieves the major milestone of one billion vaccinations

    In a historic achievement, the cumulative COVID-19 vaccine doses administered in the country has surpassed the 100-crore milestone. In a tweet, Prime Minister Shri Narendra Modi congratulated the countrymen and expressed gratitude to the country’s scientific community and health professionals for working towards achieving this stupendous feat.

  • Govt revokes export ban on COVID diagnostic kits, reagents

    The Central Government has revoked the export ban from Covid diagnostic kits, reagents by making amendment in the export policy of diagnostic kits.

    The export restriction is lifted from VTM kits and reagents, RNA extraction kits, RT PCR kits, facon tube or cryovials, swabs sterile synthetic fibre etc. It also includes Silicon columns, Carrier RNA, Proteinase K, Magnetic Stand, Beads, Probes from COVID19 testing, primers for COVID testing, Taq polymerase enzyme, COVID19 rapid antigen testing kits.

  • NPPA condemns false statements regarding its connivance in any malpractices adopted by Pharmaceutical Companies

    National Pharmaceutical Pricing Authority is a regulatory body under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India and is committed to ensure affordability and accessibility of medicines by fixing the ceiling price for scheduled formulations and monitoring the prices of non-scheduled formulations.

  • Odisha Government allows pharmacists to dispense medicine in absence of doctors

    Due shortage of doctors in public healthcare facilities, the Odisha government has permitted pharmacists to treat minor ailments and dispense drugs for certain diseases in hospitals.

  • Biological E Covid-19 Vaccine receives DCGI approval for Two Clinical Trials

    The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India (GoI) has taken myriads of initiatives to increase investments in research & development (R&D) and manufacturing of COVID-19 Vaccines.

  • Indian Scientist Partners with BRICS Group to Setup Network of Genomic Surveillance and Study the Overlap of SARS-CoV-2 with tuberculosis

    Department of Biotechnology, Ministry of Science and Technology, Government of India in collaboration with BRICS countries is implementing SARS-CoV-2 NGS-BRICS consortium and multi centric programme to study the impact of severe COVID-19 conditions on TB patients.

  • Zycov-D, needle free COVID vaccine in the world is approved in India

    Zydus Cadila announced that the company has received the Emergency Use Authorization from the Drug Controller General of India (DCGI) for ZyCoV-D the worlds first Plasmid DNA Vaccine for COVID-19. ZyCoV-D is a three dose vaccine which will be administered first on day zero, day 28th and then on the 56th day. With this approval, India now has its first COVID-19 vaccine for the adolescents in the 12-18 age group, besides the adult population.

  • J&J COVID-19 vaccine gets approval, says Health Minister of India

     Mansukh Mandaviya, Minister of Health and Family Welfare; Chemicals and Fertilizers, Government of India has announced that Johnson and Johnson single-dose COVID-19 vaccine is given approval for Emergency Use in India.

    He said that India expands its vaccine basket. Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines.

  • New RDA rules shows increase in Iron, Zinc, Vitamin A, C, D and Calcium intake

    ICMR has revised the nutrient requirements for Indians and has published new RDAs (Recommended Dietary Allowance) in 2020 and the Food Authority has decided to adopt the same. In New RDA rules, it shows an increase in Iron, Zinc, Vitamin A, C, D and Calcium intake for Indian population.

  • GSK gets CDSCO panel nod for inactivated influenza vaccine

    GSK India has received a positive recommendation from the Subject Expert Committee, SEC, of CDSCO for inactivated influenza vaccine, split virion vaccine. The SEC recommended that permission may be granted for ages more than 64 years.

    Inactivated influenza, split virion vaccine sold under brand name Fluarix Tetra in India which helps to protect from influenza (flu). It works by exposure to a small dose of the flu virus which helps the body to develop immunity against the disease. It will not treat an existing flu virus infection.

Subscribe to Government News

Search this website